MPZL3 and hyperlipidemia: While increasing mitochondrial fatty acid oxidation alone may not reduce adiposity (Hoehn et al., 2010), the tissue specific effects we observed in Mpzl3 ASO‐treated mice could have cumulatively led to protection against the weight gain, hyperlipidemia and hyperglycemia normally seen in mice fed HED.